Skip to main content

Illumina Stock Could Illuminate This Healthcare ETF

Biotech firm Illumina, Inc. (NASDAQ: ILMN) scrapped a merger with Pacific Biosciences, but there’s still a lot to like about Illumina and for investors that can’t handle the stock’s over $300 price tag, the ARK Genomic Revolution Multi-Sector Fund (NYSEArca: ARKG) is an adequate...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.